Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of gene therapy

'develop':31 'diseas':13 'disord':15 'edit':2,23,26 'field':18,34 'gene':1,22,25,36 'genet':12 'medic':4 'name':3,27 'pharmaceut':28 'research':7,29 'scientif':6 'therapi':24,37 'treatment':10 'vivo':21

Cells for medical or clinical use in the field of gene therapy for the treatment of cardiovascular diseases and thromboembolic diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy

'agent':27 'biopharmaceut':26 'cardiovascular':17,32,60 'cell':1 'clinic':5 'deliveri':54 'diseas':18,21,33,36,61,64 'disord':23,38,66 'field':9,41,69 'gene':11,43,45,49,71 'medic':3 'modul':52 'name':48 'pharmaceut':24,55 'product':47 'regul':51 'therapi':12,44,46,72 'thromboembol':20,35,63 'transfer':50 'treatment':15,30,58 'use':6

CTX611

Owner

Goods & Services